Skip to content

MT Pharma: what changed

BE 1000.033.178NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€33,835
2024 · -€54,108+€20,273
Equity
-€47,943
2024 · -€14,108-€33,835
Cash
€9,343
2024 · €52,035-€42,692
Balance sheet total
€697,338
2024 · €708,409-€11,071

Largest movements

2024 to 2025
Assets
  • Cash -€42,692

    down €42,692 (-82.0%), from €52,035 to €9,343

    mainly Investment in fixed assets (net) (-€64,447) and Debts after one year (-€44,231)

  • Tangible fixed assets +€20,809

    up €20,809 (+4.0%), from €520,629 to €541,438

    of which Plant, machinery and equipment: +€33,951

  • Receivables within one year +€18,757

    up €18,757 (+70.4%), from €26,637 to €45,395

    of which Trade receivables: +€25,216

Equity and liabilities
  • Other debts +€47,010

    up €47,010 (+97.8%), from €48,073 to €95,083

  • Debts after one year -€44,231

    down €44,231 (-8.9%), from €498,034 to €453,803

  • Profit (loss) carried forward -€33,835

    down €33,835 (-62.5%), from -€54,108 to -€87,943

  • Trade debts +€22,436

    up €22,436 (+19.5%), from €115,166 to €137,602

Income statement
  • Gross operating margin +€78,953

    up €78,953 (+209%), from €37,693 to €116,646

  • Staff costs +€39,349

    up €39,349 (+96.1%), from €40,966 to €80,315

  • Depreciation +€18,606

    up €18,606 (+64.7%), from €28,763 to €47,369

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€54,108
Gross operating margin +€78,953
Staff costs -€39,349
Depreciation -€18,606
Other operating charges +€407
Financial income -€87
Financial charges -€620
Taxes -€424
Result 2025 -€33,835
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€69,370
Investment -€64,447
Financing -€47,615
Cash 2024 €52,035
Net result for the year -€33,835
Depreciation +€47,369
Stocks and contracts +€4,323
Receivables within one year -€18,757
Smaller working-capital items -€230
Trade debts +€22,436
Tax, wage and social debts +€1,053
Other debts +€47,010
Investment in fixed assets (net) -€64,447
Debts after one year -€44,231
Current portion of long-term debt -€3,384
Cash 2025 €9,343
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €708,409 €697,338 -€11,071 -1.6%
Fixed assets 21/28 €556,702 €573,779 +€17,078 +3.1%
Intangible fixed assets 21 €36,073 €32,341 -€3,732 -10.3%
Tangible fixed assets 22/27 €520,629 €541,438 +€20,809 +4.0%
Land and buildings 22 €260,103 €251,522 -€8,581 -3.3%
Plant, machinery and equipment 23 €242,260 €276,211 +€33,951 +14.0%
Furniture and vehicles 24 €18,266 €13,705 -€4,561 -25.0%
Current assets 29/58 €151,708 €123,559 -€28,149 -18.6%
Stocks and contracts in progress 3 €70,935 €66,612 -€4,323 -6.1%
Stocks 30/36 €70,935 €66,612 -€4,323 -6.1%
Amounts receivable within one year 40/41 €26,637 €45,395 +€18,757 +70.4%
Trade receivables 40 €20,179 €45,395 +€25,216 +125%
Other amounts receivable 41 €6,459 - -€6,459
Cash at bank and in hand 54/58 €52,035 €9,343 -€42,692 -82.0%
Deferred charges and accrued income 490/1 €2,100 €2,209 +€109 +5.2%
Total equity and liabilities 10/49 €708,409 €697,338 -€11,071 -1.6%
Equity 10/15 -€14,108 -€47,943 -€33,835 -240%
Contributions 10/11 €40,000 €40,000 = 0.0%
Profit (loss) carried forward 14 -€54,108 -€87,943 -€33,835 -62.5%
Amounts payable 17/49 €722,517 €745,281 +€22,764 +3.2%
Amounts payable after more than one year 17 €498,034 €453,803 -€44,231 -8.9%
Financial debts 170/4 €498,034 €453,803 -€44,231 -8.9%
Amounts payable within one year 42/48 €224,362 €291,478 +€67,116 +29.9%
Current portion of amounts payable after more than one year 42 €48,240 €44,856 -€3,384 -7.0%
Trade debts 44 €115,166 €137,602 +€22,436 +19.5%
Suppliers 440/4 €115,166 €137,602 +€22,436 +19.5%
Taxes, remuneration and social security 45 €12,883 €13,936 +€1,053 +8.2%
Taxes 450/3 €4,183 €6,246 +€2,062 +49.3%
Remuneration and social security 454/9 €8,700 €7,691 -€1,009 -11.6%
Other amounts payable 47/48 €48,073 €95,083 +€47,010 +97.8%
Accrued charges and deferred income 492/3 €120 - -€120
Remuneration, social security and pensions 62 €40,966 €80,315 +€39,349 +96.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €28,763 €47,369 +€18,606 +64.7%
Other operating charges 640/8 €1,936 €1,529 -€407 -21.0%
Gross operating margin 9900 €37,693 €116,646 +€78,953 +209%
Operating profit (loss) 9901 -€33,973 -€12,568 +€21,405 +63.0%
Financial income 75/76B €88 €0 -€87 -99.5%
Recurring financial income 75 €88 €0 -€87 -99.5%
Financial charges 65/66B €20,199 €20,819 +€620 +3.1%
Recurring financial charges 65 €20,199 €20,819 +€620 +3.1%
Profit (loss) for the period before taxes 9903 -€54,084 -€33,387 +€20,697 +38.3%
Income taxes 67/77 €24 €448 +€424 +1,796%
Profit (loss) for the period 9904 -€54,108 -€33,835 +€20,273 +37.5%
Profit (loss) for the period to be appropriated 9905 -€54,108 -€33,835 +€20,273 +37.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€80,284

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€47,943
Intangible fixed assets (21)
-€32,341
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€80,284

Capitalised earnings

net result for the year (9904)
2025
-€33,835
2024
-€54,108
Average result
-€43,971
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.